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Cell Cycle-controlled and Bone-related Genes1
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Gary S. Stein
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ABSTRACT
Cell density-induced growth inhibition of osteosarcoma cells (ROS 17/
2.8) results in the shutdown of proliferation-specific (listone H4 and H2B
genes and the concomitant up-regulation of several osteoblast-related
genes. In several respects, this reciprocal regulatory relationship is anal
ogous to the proliferation/differentiation transition stage during develop
ment of the bone cell phenotype in normal diploid osteoblasts. Here, we
comprehensively analyzed the promoter binding activities interfacing with
key regulatory elements in the cell cycle-dependent histone and bone-
specific osteocalcin genes. Similarly, we examined factors interacting with
a series of general transcription regulatory elements that are present in a
broad spectrum of promoters. The results show that histone promoter
binding activities HiNF-D, HÃŒNF-P/H4TF-2,H4UA-1, and OCT-1, as well
as AP-1 activity, are proliferation dependent. These factors decline coor-
dinately during the cessation of proliferation in both ROS 17/2.8 bone
tumor cells and normal diploid osteoblasts. Collective down-regulation of
these trans-activating factors occurs in both cell types within the physio
logical context of constitutive regulation of ubiquitous transcription fac
tors (Spl, ATF, and ('('VAI binding proteins). In addition, during growth
inhibition of ROS 17/2.8 cells we observe a complex series of modifications
in protein/DNA interactions of the osteocalcin gene. These modifications
include both increased and decreased representation of promoter factor
complexes occurring at steroid hormone response elements as well as
tissue-specific basal promoter sequences. These results demonstrate cell
growth regulation of the promoter factors binding to the proliferation-
specific histone and tissue-specific osteocalcin genes during the cessation
of proliferation.
INTRODUCTION
Osteosarcoma cells (ROS 17/2.8) continuously express a series of
bone-related genes (1, 2) that in normal diploid cells or in vivo are
expressed only postproliferatively (3, 4). The expression of genes
characteristic of postproliferative stages of osteoblast differentiation
(e.g., OC,2 AP, and OP) occurs concomitantly with the expression of
cell growth-regulated genes required for ordered progression through
the cell division cycle (e.g., histones H4, H3, H2B. H2A, and HI) (3,
5). Comparison of gene regulatory mechanisms operative in ROS
17/2.8 cells with those functioning in normal diploid rat osteoblast
allows an assessment of the extent to which relationships between
proliferation and differentiation are compromised during neoplastic
transformation.
Differentiation of ROBs derived from fetal calvarial bone occurs in
three well-defined stages (6-11; reviewed in Refs. 3 and 12). First,
actively proliferating ROB cells express cell growth-related genes and
genes associated with extracellular matrix biosynthesis (e.g., type I
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/incethanesulfonic acid; VDRE. vitamin D response element; nt. nucleolide; SSC, stand
ard saline citrate; SDS. sodium dodecyl sulfate.
collagen, fibronectin. transforming growth factor /3). Subsequently, at
a critical transition point, an integrated series of signaling mechanisms
mediates cessation of cell division, resulting in the down-regulation of
proliferation-specific genes and the initiation of osteoblast phenotype
gene expression (e.g., AP). As a result of genes expressed during both
the initial proliferative and the immediate postproliferative periods,
the extracellular matrix is rendered competent for the ordered depo
sition of hydroxyapatite by mature osteoblasts. Extracellular matrix
mineralization is initiated at a second transition point, coincident with
the up-regulation of mature bone phenotypic genes, including OC and
OP. This staged cascade of sequential gene expression is controlled to
a significant extent at the transcriptional level.
The stringently orchestrated expression of diverse genes accompa
nies and is required for the normal development of bone tissue, but
osteosarcoma cells do not produce a bone tissue-like organization in
culture. However, in these cells increased expression of bone-related
genes and shutdown of proliferation-specific genes are clearly evident
following cell density-dependent growth inhibition (1, 4). Thus, it is
important to assess gene regulatory mechanisms operative during the
proliferation arrest of ROS 17/2.8 cells for comparison with those
occurring at the analogous key transition stage during normal osteo
blast development.
To address transcriptional mechanisms during osteoblast develop
ment our laboratory has focused on the regulation of histone and
osteocalcin genes (Refs. 10 and 13: reviewed in Ref. 14). Transcrip
tion of vertebrate proliferation-specific histone genes ( 15-24) and the
bone-specific osteocalcin gene (25-31) is controlled by multiple evo-
lutionarily conserved fra/ii-activating factors interacting at a series of
well-defined promoter recognition sites. The regulation of several of
these DNA binding activities has been studied in relation to modula
tions of transcription during progressive development of the osteoblast
phenotype (4, 13, 25, 32). These studies provide insight into transcrip
tional mechanisms controlling the individual histone and osteocalcin
genes and address aspects of the developmental regulation of key
nuclear factors executing the selective expression of these and other
target genes. In this study, we compare regulatory events occurring
during the cessation of ROS 17/2.8 proliferation with those occurring
during normal osteoblast differentiation to gain insight into the mech
anisms mediating stringent growth control of gene expression. We
observe reciprocal and cell density-dependent modifications in the
expression of a series of proliferation-specific (e.g., histone H4 and
H2B) and tissue-specific (e.g., OC, OP, and AP) genes during growth
inhibition of osteosarcoma cells. We systematically examined regula
tion of the entire complement of promoter DNA-binding activities that
have been characterized previously and shown to interact with histone
H4 (17, 21-36) and osteocalcin (25-27, 29. 30, 37) promoters to
evaluate potential mechanisms controlling these reciprocal gene reg
ulatory events.
MATERIALS AND METHODS
Cell Culture. Rat osteosarcoma cells (ROS 17/2.8; Merck, Sharp and
Dohme. West Point, PA) were grown in F12 media (Gibco. Grand Island, NY)
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and supplemented with 5% horse serum (ICN. CA). Cells (passage 18. passed
by subcultivation every 8-10 days) were seeded at a density of 1 X IO6
cells/150-mm dish. Osteocalcin samples were taken from the media every
other day and analyzed by radioimmunoassays (38). At days 3, 5, 7, and 10 2-5
dishes were processed for mRNA (Fig. 1) and nuclear run-on analysis (4).
Nuclear extracts were made at days 5 and 10 after the cells were plated.
ROB were isolated from 21-day-old rat calvaria by sequential enzyme
digestions as described (6, 39). Cells were passaged at confluency. seeded at a
density of I X 10" cells/150-mm dish, and maintained in minimal essential
media (Gibcu) supplemented with 10% fetal calf serum (HyClone. Logan.
Utah). 50 pg/ml ascorbic acid, and 10 ITIMÃŸ-glycerolphosphate while changing
media every other day. Proliferating ROB cells were collected 2 days after
plating, and differentiated cells were harvested at day 30.
Northern Blot Analysis. Total RNA was extracted from cell pellets as
described previously (40), with a LiCl precipitation procedure. RNA samples
were quantitated by absorbance at 260 nm and electrophoresed on a 6.6%
formamide-1% agarose gel. The integrity of the RNA was assessed by ethid-
ium bromide staining. RNA was transferred to a zeta-probe membrane (Bio-
Rad, Richmond. CA) and hybridized with probes as indicated in the figure
legend. The probes were labeled with [a-12P]dCTP by using a Prime-It kit
(Stratagene. La Jolla. CA). Prehybridizations and hybridizations were per
formed at 42Â°C in 50% formamide. 5X SSC (20 x SSC = 0.3 M sodium
chloride, 0.3 M sodium citrate), 10X Denhardt's solution, 50 HIM sodium
phosphate (pH 6.5). 1% SDS. and 250 (jg/ml salmon sperm DNA. For hybrid
izations IO6cpm/ml probe were added, and the salt concentration was adjusted
by adding 20x SSC. Blots were washed at 60Â°C.three times in 20X SSC,
0.1% SDS and two times in IX SSC, 0.1% SDS. The blots were exposed to
X-AR (Eastman Kodak Company. Rochester. NY).
Probes for Protein/DNA Interactions. The probes used in this study were
prepared from synthetic oligonucleotides (17. 26, 36, 48) which were quanti
tated and 5' end-labeled using T4 polynucleotide kinase according to standard
procedures (17,41). The radiolabeled DNA fragment used to measure HiNF-D
activity was plasmid derived and encompasses the proximal promoter region
of the H4-F0108 histone gene (spanning nt -97 to -38, cap site at nt -30)
(36).
Preparation of Nuclear Extracts. The preparation of nuclear extracts from
rat osteosarcoma cells was performed as described previously (36.42). Nuclear
extracts from rat osteoblasts were prepared as follows. Collected cells were
lysed in 5 ml lysis buffer/10" cells (10 ITIMKC1, 0.5% Nonidet P-40. 10 HIM
HEPES. pH 7.5). and 20 ml of solution A (0.32 M sucrose, 11% w/v; 0.01%
Nonidet P-40; and 5 mm HEPES. pH 7.5) were added. This suspension was
carefully layered over 10 ml solution B (2.1 Msucrose, 72% w/v; 5 ITIMHEPES.
pH 7.5). The nuclei were recovered as a pellet after centrifugation (Beckman
SW 27 rotor. 13.000 rpm, for 45 min, at 4Â°C).The nuclei were washed with
solution C ( 10 msi KC1. 10 ITIMHEPES) and recovered by centrifugation (IEC,
1500 rpm. for 5 min, at 4Â°C).The pellet was resuspended in extraction buffer
(420 mm KC1, 0.2 HIMEDTA, 20 ITIMHEPES, pH 7.5) in a 1.5-ml microcen-
trifuge tube, using approximately 0.5 ml for 1 X 10" nuclei. The nuclei were
extracted for 30 min by rotating at 4Â°Cand removed by centrifugation at
14.(XX) rpm for 15 min at 4Â°C. During the extraction procedure a broad
spectrum of fresh protease inhibitors was used (phenylmethylsultbnyl fluoride,
leupeptin, pepstatin, trypsin inhibitor, tolylsulfonyl phenylalanyl chloromethyl
ketone, at concentrations recommended by Boehringer Mannheim. Indianap
olis. IN). Desalting of the nuclear extracts was performed by diluting with
storage buffer without KCI (KNO buffer: 20% glycerol; 0.2 imi EDTA; 0.01%
Nonidet P-40; 25 mm HEPES, pH 7.5; and 1 min dithiothreitol). The protein
concentration was determined by Bradford analysis (Pierce).
Gel Retardation Assays. Gel retardation assays were performed as de
scribed previously (17, 43). Protein/DNA binding reactions were obtained by
combining 10 (jl of a protein mixture (in KN100 buffer, which is as KNO buffer
but contains 100 rmi KC1) with 10 jil of a DNA mixture, including probe DNA
(10-50 fmol), 1 ITIMdithiothreitol. and nonspecific competitor DNA. In most
gel retardation assays 0.1 (Jg/nl poly (dl-dC)-(dl-dC) was used as a nonspecific
competitor. The type and amount of nonspecific competitor DNA used for the
detection of the sequence-specific DNA binding activities described in this
study [e.g.. poly (dG-dC)-poly (dG-dC) and poly (dA-dT)-poly (dA-dT)] were
optimized for the detection of each factor as indicated in the figure legends.
Competition assays were performed with a 50- to 100-fold molar excess of
specific competitors (described in the figures) by incubation with the DNA
mixture prior to addition of the protein mixture. The samples were loaded on
a 4% polyacrylamide gel with various acrylamide:bisacrylamide cross-linking
ratios and buffer conditions as optimized for the different proteins; i.e., inter
actions of HiNF-D, ATF, SP1, API, CCAAT, and OCT-I were studied using
[80:11 gels with LIS buffer (43); factors HiNF-M and HiNF-P were detected
using [20:1] gels with TGE buffer (50 m.MTris, 380 rriMglycine, 2 HIMEDTA.
pH 8.5) (41): protein/DNA interactions at the VDRE, OC box, and TATA
region were analyzed using [40:1] gels with TBE buffer (89 ITIMTris. 89 m.M
Borate. 2 ITIMEDTA, pH 8.4) (4).
RESULTS
Reciprocal Patterns of Gene Regulation during Cell Density-
induced Growth Inhibition of ROS 17/2.8 Cells. Cultures of ROS
17/2.8 cells are subject to an initial period of active growth (day 0 to
day 6 after plating) (Fig. \A), during which a low level of OC
secretion into the culture medium is detected (Fig. IÃŸ)and high levels
of H4 and H2B gene expression are observed (Fig. 1C). In the sub
sequent stage -day 7 to day 10), OC secretion reaches maximum levels
(Fig. IÃŸ),and the levels of H4 and H2B mRNA are down-regulated
below the level of detection (Fig. 1C). Because of the tight linkage
between histone mRNA levels. DNA replication, and progression
through S phase in the cell division cycle (14, 44), these results
indicate that under these culture conditions ROS 17/2.8 cells cease to
proliferate and enter a cell growth-inhibited state. In contrast to the
down-regulation of proliferation-specific histone genes, constitutive
levels of type I collagen expression are observed, whereas the expres
sion of OC, OP, and AP genes is up-regulated above basal levels
initially observed in actively dividing ROS 17/2.8 cells (Fig. 1C).
These results suggest that the levels of OC, OP, and AP gene expres
sion are coupled in part to the cessation of cell proliferation.
Coordinate Regulation of H4 Gene Promoter Factors HiNF-D,
HÃŒNF-P/H4TF-2,and H4UA-1 during Cessation of ROS Prolifer
ation. The down-regulation of histone H4 and up-regulation of OC
gene expression during density-induced growth inhibition of osteo
sarcoma cells is mediated in part by changes in gene transcription
rates as measured by nuclear run-on analysis (4). Multiple promoter
factors involved in the control of histone and osteocalcin genes have
been extensively studied. Transcriptional control of histone H4 gene
expression during the onset of differentiation is reflected by selective
modifications in interactions of /ra/rs-activating factors with both
proximal and distal m-acting elements (13, 17, 33, 35, 45). However,
the regulation of H4 promoter factors has not been assessed at the
cessation of cell proliferation, irrespective of mechanisms mediating
the initial onset of differentiation. To gain insight into regulation of
both H4 gene transcription as well as the corresponding control of H4
promoter factors, we analyzed the entire complement of H4 promoter
DNA binding activities when ROS 17/2.8 cells become cell growth
inhibited. We used a comprehensive panel of promoter segments (Fig.
2), representing all protein/DNA recognition sites established for a
prototypical H4 gene in gel mobility shift assays. We monitored
binding activities interacting with each DNA probe using nuclear
protein preparations of actively proliferating (day 5) and density-
inhibited (day 10) ROS 17/2.8 cells (Figs. 3 to 5). Our results show
that factors HiNF-D (Fig. 3A), HÃ•NF-P/H4TF-2 (Fig. 3ÃŸ),and
H4UA-1 (Fig. 3C) are not detected in cell density-inhibited ROS
17/2.8 cells. In comparison, HiNF-M (Fig. 3ÃŸ)is present in ROS
17/2.8 cells both early and late during the culturing period. These
results indicate that the binding activities of HiNF-D and HiNF-P/
H4TF-2 are selectively down-regulated, whereas HiNF-M binding
activity is constitutive.
The interactions of HiNF-D, HÃ•NF-P/H4TF-2, and HiNF-M occur
ring at the cell cycle regulatory region of this gene (designated H4 Site
II) have been studied in detail previously by, i.e., methylation inter-
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ference and mutational analyses ( 17. 36). Unambiguous assignment of
these factors in this study is based on competition analyses using
specific wild-type and mutant competitors (see Fig. 3. right) as well
as exact comigration with previously characterized protein/DNA com
plexes. However, distinct probes spanning H4 Site II sequences will
also interact less reproducibly with uncharacterized and mostly non
specific factors (e.g., see Fig. 3. A and B). For example, a band
migrating more slowly than the HiNF-M complex is observed in both
proliferating and confluent cells (Fig. 3ÃŸ,band NS). This and other
nondesignated bands represent nonspecific DNA binding proteins,
because in each case no competition is observed with specific oligo-
nucleotides. Similarly, unidentified complexes were observed with
most of the other factor-specific probes used in this study, and anal
ogous explanations apply in each case.
Two complexes migrating faster than the HÃŒNF-P/H4Site II inter
action occur with proteins from confluent cells (Fig. 3ÃŸ).We have
previously shown that there is at least one posttranslationally modified
electrophoretic variant of HiNF-M (36). Whereas HiNF-M may be a
phosphorylated heteromeric factor, to date only a single electro
phoretic form of the HÃŒNF-P/H4TF-2complex is known (17, 34).
Competition characteristics of these two high-mobility complexes are
indistinguishable from those of HiNF-M (data not shown), suggesting
a relationship with HiNF-M. The physiological significance of the
abundance of these factors in confluent cells, when HiNF-M activity
persists, remains to be established.
Binding Activities of Ubiquitous Transcription Factors Remain
Constitutive during ROS 17/2.8 Cell Density Inhibition. Members
of transcription factor families with broad promoter binding specific
ity, including Spl-, ATF-. and CCAAT box-related factors (46), have
been shown to interact with the promoters of several distinct histone
gene subtypes (e.g.. H4. H3, and HI ) using several in vitro (35. 36, 47.
48) and in vivo (49. 50) approaches. The nuclear abundance of pro
moter factors binding to Spl. ATF, and CCAAT elements is similar in
proliferating and density-inhibited ROS 17/2.8 cells (Fig. 4). For
example, Spl (Fig. 4A), ATF-84 (Fig. 4B). and CCAAT box protein
HiNF-B (Fig. 4C) remain constitutive in both proliferating and con
fluent ROS 17/2.8 cells. The constitutive presence of these factors is
consistent with their postulated roles in regulating general ("house
keeping") and tissue-specific genes (46). In addition, these results
provide qualitative and quantitative internal standards for the general
integrity and extractability of nuclear factors in our protein prepara
tions, apart from normalization based on protein content.
Fig. I. A. rat osleosarcoma cells (ROS 17/2.8I
cultured m vilnt during density-induced cell growth
inhibition. The photomicrographs were taken at days
3. 5, 8. and 10 after cell plating. B. osteocalcin pro
duction per day as determined hy radioimmunoas-
says. The graph shows the increase in osteocalcin
secretion into the culturing media when ROS 17/2.8
cells reach confluency. Each point represents the av
erage of 5 samples, which were taken from the media
of 5 different plates. C left. Northern blot analysis of
total cellular RNA from ROS I7/2.8 cells during the
cessation of proliferation. Blots were analyzed for
the representation of mRNAs encoded by cell cycle-
dependent and tissue-specific genes. The probes used
span mRNA coding sequences of H4. H2B. OC. AP,
OP, or type I collagen (coll) and were prepared as
reported previously (40. 60). The figure shows that
the abundance of cell cycle-dependent histone H4
und H2B mRNAs decreases during density inhibition
of rat osteosarcoma cells, whereas the levels for os
teocalcin. alkaline phosphatase. and osteopontin in
crease. On the rÃ¬dili,the integrity of mRNA extracted
from rat osleosarcoma cells is shown in an cthidium
bromide-stained gel. Each lane contains 10 ng of
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Fig. 2. The probe DNA fragments used in this study are shown relative to the modular
organization of a prototypical cell cycle-regulated histone H4 gene promoter (top] and the
bone-specific OC gene promoter (btittom ). The nucleotide positions are indicated for each
probe, except the Spl oligonucleotide, which conforms to an Spl consensus element. The
histone H4 promoter contains a series of proximal and distal transcriptional domains (H4
Sites I to III) (/wuf.v). These domains are bipartite and multipartite, and each interacts with
several promoter factors as indicated (e.g.. HiNF-D. Spl. and H4UA-1; reviewed in Refs.
14 and 17). The ostewalcin promoter contains steroid hormone response elements (e.g..
VDRE) and basal tissue-specific elements (OC box and TATA box). Whereas the OC gene
represents a single gene in the rat genome (28). the H4 gene is present in multiple copies
(44). each with a different organization of promoter elements. The distribution of protein/
DNA interactions indicated in the diagram represents that of the human H4-FOI08 gene,
which has been most extensively studied ( 14, 17). Each of the evolutionary conserved
promoter elements depicted here has homologous counterparts in the promoters of several
other vertebrate H4 genes, as well as other histone gene subtypes ( 17, 44).
Down-Regulation of the Binding Activities of Histone H2B
Gene Transcription Factor OCT-1 and the FOS/JUN-related On-
coprotein AP-1. The octamer transcription factor OCT-I was iden
tified initially as a critical histone H2B gene fra/w-activating protein
(51). OCT-I belongs to a class of homeo- and POU/homeo-domain
proteins that recognize the octameric sequence 5'-dATTTGCAT (52)
and perform important gene-regulatory roles during development
(53). The binding activity of OCT-I is cell growth regulated in several
cell types (53. 54, 55). but regulation of OCT-I has not been studied
in bone cells. Our data show that OCT-1 binding activity is detectable
in proliferating ROS 17/2.8 cells but is absent in ROS 17/2.8 cells that
are density inhibited (Fig. 5/4). Together with results presented in
Figs. 1C and 3, these findings establish that down-regulation of H4
and H2B gene expression in ROS I7/2.8 cells (Fig. 1C) corresponds
with the down-regulation of the key cognate factors HiNF-D and
HÃ•NF-P/H4TF-2 for the H4 gene (Fig. 3, A and B) and OCT-1 for the
H2B gene (Fig. 5/1).
The AP-1 oncoprotein family represents a heterogeneous class of
transcription factors that are intimately associated with cell growth-
related intracellular signaling mechanisms (56, 57). AP-1 activity is
thought to be involved in the positive regulation of several but not all
histone genes (20) and is implicated in the cell growth-related sup
pression of basal level osteocalcin gene expression during osteoblast
development (3, 26). The dual role of AP-1 proteins in the potentially
negative or positive influence of gene transcription is consistent with
the versatile role of AP-1 in developmental regulation (56, 57). Our
results show that AP-1 binding activity is down-regulated in growth-
inhibited ROS 17/2.8 cells (Fig. 55). Hence, cell growth regulation of
AP-1 binding activity correlates with both the up-regulation of the
basal level of OC gene expression and the down-regulation of histone
A PROL. CONFL C S N
PROL CONFL OK O Z 5 Q
â€¢¿â€¢ -ns
CONFL C S1 N S2
H4UA1Â».
Fig. 3. Protein/DNA interactions at Sites II and III of the H4 gene promoter during
growth inhibition of ROS 17/2.8 cells. In A, HiNF-D activity is detectable in proliferating
rat osteosarcoma cells (first 3 lanes from the left. 2.5. 3.8, and 5 ug nuclear protein,
respectively) but not in density-inhibited ROS cells (muidle 3 lanes, Â¡eftto right, 2.5, 3.8,
and 5 (jg, respectively). Competition analysis was performed in the presence of 5 ug
protein from proliferating ROS 17/2.8 cells with a I(X)-fold molar excess of either a
specific oiigonucleotide spanning the HiNF-D binding site (designated TM3; Lane Si that
competes ora HiNF-D mutant oligonucleotide (SUB-ll; Lane N) that does not compete
(17). The probe spans H4-Site II (nt-97 lo-38) of the H4 gene promoter (Â£YÂ»Rl////m/III
fragment of pFP202 (41 ). B, HiNF-M binding activity is detectable in proliferating as well
as in density-inhibited rat osteosarcoma cells, whereas the level of HiNF-P decreases to
below the limit of detection during growth inhibition. Nuclear extracts from both prolif
erating (PROL ) and confluent (CONFL. ) ROS I7/2.8 cells were used in the assay. The
amount of nuclear protein used in each binding reaction was, respectively, 5, 7.5, and 10
ug for each preparation. Competition analysis is shown in 5 right-hand lanes using
oligonucleolides (described in detail in Ref. 17) that compete for both HiNF-P and
HiNF-M ( TM3)OT specifically compete for either HiNF-P (NH6) or HiNF-M (DD-ÃŒ) and
specifically mutated DNA fragments that do not compete for HiNF-P (G7V) or HiNF-M
(INSfOi. us, nonspecific complex. The probe fragment encompasses Site II of the histone
H4-FO108 gene promoter and spans nt -97 to -38; binding reactions were performed in
the presence of I ug salmon sperm DNA. In C. H4UA-1 binding activity decreases during
osteosarcoma cell growth inhibition. Shown is a gel retardation assay monitoring the
abundance of H4UA-I binding activity interacting with Site III of the H4 gene promoter
using nuclear extracts from proliferating (PROL. ) and density-inhibited (CONFL ) ROS
17/2.8 cells. The amounts of protein loaded for each extract were, respectively, 2.5, 3.8,
and 5 ug. First lane un the left, pattern obtained using 5 ug of protein from HeLa S3 cells.
Competition analysis was performed with 5 ug protein from proliferating ROS 17/2.8 cells
in the absence of competitor DNA (C) or in the presence of specific competitor (SI. H4
Site III. spanning nt -369 to -323; 52, proximal part of H4 Site III (nt -349 to -323) or
nonspecific competitor (N; distal pan of H4 Site III (nt -369 to -349). The probe for H4
Site III encompasses nt -326 to -371 and was used in the presence of 2 ug poly
(dA-dT)-poly (dA-dT) DNA and 1 ug poly (dl-dC)-poly (dl-dC) as described previously
(33).
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HiNF-D, HÃŒNF-P/H4TF-2,and H4UA-1 (Fig. 3C) as well as OCT-l
binding activity (Fig. 5A). The down-regulation of this series of
proliferation-related transcription factors during cell growth inhibition
of ROS 17/2.8 cells may reflect global modifications of gene-regula
tory mechanisms.
Protein/DNA Interactions in the OC Promoter during Dp-Reg
ulation of OC Gene Expression from Basal Level. Regulation of
osteocalcin transcription is mediated by several distinct transcriptional
mechanisms, including the involvement of factors regulating tissue-
specific basal levels of transcription and steroid hormone responsive
ness (e.g., the synergistic and/or antagonistic interplay of vitamin D
and glucocorticoid) (3, 5). In addition, a postulated model for tran
scriptional repression may be operative whereby AP-l protein inter
acts with specific sites in the OC promoter and suppresses the osteo-
blast phenotype-specific expression of the OC gene (26). Vitamin D
and dexamethasone-inducible protein/DNA interactions have been ex
tensively studied during osteoblast development at three key cis-
acting elements in the OC promoter (see Fig. 2): respectively, the
VDRE, the OC box, and the most proximal promoter region contain
ing the TATA box region (4, 25-27, 32, 37). However, to date regu
lation of OC promoter element occupancy in the absence of exoge
nous, pharmacological doses of steroid hormones has not been studied
Ã•PBQL, CONFL. C S N
PROL. CONFL. C S N
CCAAT - Ãœ ->-â€¢- â€”¿ IE
M
Fig. 4. Analysis of genera! transcription factor binding activities in nuclear extracts
derived from proliferating and density-inhibited rat osteosarcoma cells. A, Spl binding
activity was assayed in nuclear extracts from proliferating (PROL. ) and growth-inhibited
(CONFL ) ROS 17/2.8 cells. The^/rcr lane on the left shows Spl binding activity present
in HeLa nuclear extracts (6 ug); Lanes 2-4 from Â¡heleft, 1.9, 2.9, and 5.8 ug of nuclear
protein, respectively, from proliferating cells; Laines 5-7 from the left, 2, 4, and 6 ug of
nuclear protein, respectively, from growth-inhibited cells. The probe is a consensus Spl
binding site oligonucleotide (36) similar to the sequence present in the proximal portion
of H4-Site I {Fig. 2). In B, total ATF binding activity (a and b) was monitored during
density inhibition of rat osteosarcoma cells. The first lane from the left contains 2.5 ug
protein from HeLa cells; Lanes 2-4 from the left, 2.3, 4.5. and 6.8 ug protein, respectively,
from proliferating ROS 17/2.8 cells; Lanes 5-7 from the left, 3,4.8. and 6.3 ug of protein,
respectively, from density-inhibited osteosarcoma cells. The probe spans the ATF binding
site present in the distal portion of H4-Site 1 (nt -154 to -128; DS-I oligonucleotide) in
the H4-FO108 gene promoter. The biological importance of differences in relative band
intensities of complexes a und h is not clear. For example, this ratio varied from prepa
ration to preparation with proliferating cells, and we could not discern a consistent pattern.
In C protein/DNA interactions at the CCAAT-box element of the H3 histone gene
promoter was analyzed during growth inhibition of osteosarcoma cells. IÂ¿meHEIA, 7.5
jag protein from HeLa nuclei; Lanes 2-4 from the left, 3.9. 7.7, and 11.5 ug protein,
respectively, from proliferating ROS 17/2.8 cells; Lanes 5-7from the left, 2.5, 3.8. and 5
Ug protein, respectively, from density-inhibited ROS. The CCAAT sequence used as probe
is derived from the histone H3-ST519 gene promoter (nt -139 to -110) (48). Competition
analysis was performed with 5 ug protein from HeLa nuclear extracts in the presence of
no competitor (Lane C), the unlabeled CCAAT element oligonucleotide as specific com
petitor (iMne S), or the Spl fragment as nonspecific competitor (Lane N).
gene expression (Fig. 1). Moreover, the decrease in overall AP-l
Â«WM M H -
B <
C S N
Fig. 5. A, OCT-l binding activity decreases during density inhibition of rat osteosar
coma cells. Lane HELA, I ng HeLa nuclear protein. The amounts of protein loaded from
proliferating ROS (luanes 2-5from the left) and from density-inhibited ROS (Â¡Mnes6-V
from the left) cells were, respectively, 0.4, 0.8. 1.1. and 1.5 ug in each set. The probe used
a synthetic oligonucleotide spanning an OCT-l element of a human H2B gene (51), and
2 fjg of poly (dl-dC)-poly (dl-dC) were present in the binding reaction. Competition
analysis was performed with the unlabeled OCT-l DNA fragment (lÂ¿me5). with the Spl
oligonucleotide (Lane N), or in the absence of competitor DNA fragments (Lune C] using
I ug HeLa nuclear protein. B, AP-1 binding activity is present in proliferating (PROL. ) but
not in confluent (CONFL.) ROS cells. For both nuclear extract preparations, binding
reactions contained, respectively. 2.5. 3.8, and 5 ug protein. Competition analysis was
performed with 5 ug protein from confluent ROS 17/2.8 cells using the following DNA
fragments, respectively: Lane 3 from the left, no competitor DNA added (C); Line 4 from
the Â¡eft,AP-l as specific competitor (5) and lane 5 with SPI as nonspecific competitor
(N). The probe is a synthetic AP-l consensus oligonucleotide (26), and 2 ug of poly
(dl-dC)-poly (dl-dC) were present in the binding reaction. The protein/DNA complexes
activity OCCUrS in Concert with the decline in H4 promoter factors were separated on a 4% (40:l) polyacrylamide gel using TGE buffer.
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Fig. 6. Protein/DNA interactions in the osteoealcin gene promoter during growth
inhibition of rat osteosarcoma cells. A. nuclear proteins interacting with the rat vitamin
D-responsive element (nl -462 to -437) are observed in both proliferating (PROL) and
density-inhibited (CONFL} ROS cells (for each set, respectively, 1.25, 2.5, 3.8. and
5 ug protein were used). Competition assays were performed with 5 ug of nuclear ex
tract derived from proliferating ROS cells using a panel of oligonucleotides (57, unla-
beled rat osteoealcin VDRE; /V, Spl; S2, human osteocalcin VDRE). In B. the protein/
DNA interactions at the osteocalcin box are similar in proliferating (PROL.) and
confluent (CONFL. ) ROS cells. Increasing amounts of nuclear protein were used in each
comprehensively in direct comparison with the down-regulation of
proliferation-specific transcription factors.
To correlate the regulation of protein/promoter interactions at the
differentiation-specific OC promoter with cell growth-controlled
binding activities, we assessed the formation of protein/DNA interac
tions at the VDRE, OC box, and the TATA box regions during cell
growth inhibition of osteosarcoma cells (Fig. 6). The interaction pat
terns at the VDRE (Fig. 6/4) of proliferating and density-inhibited
ROS 17/2.8 cells are similar but not identical. At least two of the
protein/DNA complexes at the VDRE observed under the conditions
examined here are sequence-specific (Fig. 6/4) and reflect the binding
of a distinct basal promoter factor (VDRE complex C) as well as one
interaction involving the vitamin D receptor (VDRE complex A) (4,
27). We observed a third complex (VDRE complex B), but charac
terization of this complex is incomplete at present. VDRE complex A
competes with both the rat (Fig. 6/4, Lane SI) and human (Fig. 6A,
Lane S2) osteocalcin VDREs, because the vitamin D receptor is
capable of binding to steroid hormone half-sites present in both DNA
fragments as observed previously (27, 32). VDRE complex C com
petes only with the rat osteocalcin VDRE, suggesting that this factor
recognizes sequences that are present in the rat OC VDRE fragment
but not in the human OC VDRE fragment.
The detection of the rat vitamin D receptor by gel shift assays (i.e.,
complex A in Fig. 6/4 ) is related to activation of this steroid hormone-
binding protein by endogenous vitamin D present at low levels in the
culture medium. However, because the nuclear protein preparations
were derived from uninduced osteosarcoma cells (i.e., not treated with
additional vitamin D), the signal on the autoradiogram that represents
the vitamin D receptor complex (complex A) is weak. The similarities
in protein/DNA interactions at the VDRE of dividing and nondividing
ROS 17/2.8 cells suggests that the up-regulation of OC transcription
from minimal basal levels when ROS 17/2.8 reach confluency does
not involve dramatic changes in the levels of these DNA binding
activities interacting with the VDRE. However, we cannot exclude the
possibility that subtle differences in the representation of the com
plexes detected here may have physiological significance.
Several interactions occur at the OC box (Fig. 6ÃŸ),and one of these
(OC box complex A) involves a recently characterized protein related
to the steroid hormone receptor family. OC box complex A is pre
sumably related to two other complexes (OC box complexes B and C)
by phosphorylation-dependent protein/protein associations (58). The
constitutive presence of proteins mediating complexes A, B, and C at
the OC box during ROS 17/2.8 cell density inhibition indicates that
the basal level of OC transcription is not induced by dramatic changes
in the nuclear abundance of these DNA-binding activities. The results
obtained for factors interacting with the VDRE and OC box (Fig. 65),
in direct comparison with those presented in Figs. 3 and 5, are in
contrast to the modifications in protein/DNA interactions observed for
cell growth-controlled histone genes.
The TATA region interacts with a novel and pronounced DNA-
binding activity (TATA region complex A) that is clearly present in
proliferating cells, but its abundance is severely reduced in nonpro-
set: 3.2. 4.8, and 6.4 ^g. respectively. Competition analysis was performed with 5 ug of
confluent ROS nuclear extract (Lines 7-11 from the left) using DNA fragments spanning
nt -120 to -76 (SI), m -120 to -89 (52), nt -99 to -76 (S3), and a CCAAT box
containing oligonucleotide (N). The probe spans nt -120 to -76 of the rat osteocalcin
promoter. The final salt concentration in the binding reaction was 90 mm KG. In C, factors
binding to the probe spanning the TATA region (nt -43 to +23) are observed in nuclear
extracts prepared from proliferating (prolif.) and density-inhibited (confi.) ROS cells.
Increasing amounts of nuclear proteins were used in each set: 2.5. 3.8, and 5 ug, respec
tively. Competition analysis was performed with 5 ug protein from proliferating ROS
17/2.8 cells using DNA fragments spanning nt -43 to -16 (SI), nt -26 to +10 (S2). or
an SP1 consensus oligonucleotide (/V). Based on the conditions used here (e.g., modifi
cations in nuclear extract procedures) we do not detect glucocorticoid receptor complexes
that have been observed recently in related studies (63).
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tein. Because complexes A and B have similar competition behaviors,
it is possible that complex A is converted into complex B at conflu-
ency. Regardless of the last conclusion, the down-regulation of the
factor mediating complex A establishes that at least one protein/DNA
B PROL. PIFF.
Fig. 7. A, protein/DNA interactions to Site II of the H4 histone gene promoter during
differentiation of normal rat osteoblasts. The autoradiogram shows a gel shift assay
indicating that HiNF-D binding activity is detectable in nuclear extracts from proliferating
rat osteoblasts (Lanes I and 2 from the left. 2 and 4 ug, respectively) but not in differ
entiated rat osteoblasts (Lanes 3 and 4 from the left. 1.9 and 3.8 ug. respectively).
Competition analysis is shown in the last 3 lanes on the right. Reactions were performed
in the absence of competitor (C. control) or the presence of a 100-fold molar excess of
specific (5, TM3) or nonspecific (N, DD-I) competitor DNA fragment (17). Binding
reactions were performed using the nt -130 to -38 promoter fragment of the H4-F0108
gene cloned in pFP-1 (43) in the presence of 2 ug of poly (dG-dC)-poly (dG-dC). B.
regulation of HiNF-P and HiNF-M binding activity during rat osteoblasts differentiation
(PROL, 2.6, 3.9, and 5.2 ug; DIFF., 2.8,4.1, and 5.5 ug). Reactions were performed using
a fragment spanning nt -97 to -38 of the histone H4-FO108 gene promoter in the presence
of 1 ug salmon sperm DNA.
liferating ROS 17/2.8 cells. In contrast, a second activity (TATA
region complex B) is present primarily in confluent cells. We also
observed several weaker interactions (not indicated) mediated by fac
tors that are constitutively present in both proliferating and nonpro-
liferating ROS 17/2.8 cells, similar to the observations for the OC box
and VDRE. These minor complexes were not further characterized.
Competition analysis using oligonucleotides spanning specific por
tions of the TATA box region shows that a DNA fragment spanning
nucleotides -26 to + 10 (Fig. 6ÃŸ,Lane 52) does not compete for TATA
region complexes A and B. However, an oligonucleotide spanning
nucleotides -43 and -16 (Fig. 6ÃŸ,Lane Si) competes for both com
plexes. The presence of the TATA box consensus sequence in this
fragment and the strong detection of TATA region complex A in






Fig. 8. Gel mobility shift analysis monitoring abundance of general transcription fac
tors in nuclear extracts derived from proliferating (day 2) and differentiated (day 30) ROB
cells. In A, the radiolabeled oligonucleotide containing the Spl binding site (36) was
incubated with increasing amounts of nuclear extracts derived from HeLa S3 cells (HELA.
4 ug of protein), proliferating ral osteoblasts (PKOL. 3, 6, and 9 ug), and differentiated
rat osteoblasts (DIFF. 2. 4, and 8 ug). The last 3 lanes <mthe right represent a competition
analysis, using 12 ug protein from proliferating rat osteoblasls. Reactions were performed
in the absence of competitor DNA ( C) or in the presence of specific competitor Spl (5)
or the nonspecific competitor AP-1 (N). Additional sequence-specific complexes observed
for this probe may reflect posttranslationally modified forms of Spl (e.y-, oligomeric,
glycosylated, and/or phosphorylaled variants) (46). ÃŸ,ATF binding activity was present in
both proliferating (PROL. 0.9, 1.9, and 2.8 ug of nuclear extract) and differentiated
(DIFF.. 1.3, 1.9, and 2.5 ug) rat osteoblasts. Lanes C. S, and N. a competition assay in the
absence (C) or in the presence (5, specific ATF competitor DNA; \, nonspecific, Spl
oligonucleotide) of oligonucleotide competitor DNA. Urne HELA. 5 Mgof HeLa nuclear
protein. The probe spans the distal pan of H4-site 1 (spanning nt -154 to -128 in the H4
gene promoter). In C, the CCAAT-binding element present in the H3 histone gene
promoter interacts with nuclear proteins derived from HeLa S3 cells UMIU' HKLA. 2 ug),
proliferating rat osteoblasts (PROL. I. 1.9, and 2.9 ug). and differentiated rat osteoblasts
(DI FF.. 1.4, 2.1, and 2.8 ug). The last 3 lanes on the righi show a competition analysis in
the presence of no competitor DNA (C). with CCAAT (S) and ATF (N} as competitors.
The probe used in this assay was identical to the fragment used in Fig. 4C.
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Fig. 9. A. regulation of OCT-l binding activity to the H2B histone gene promoter
during differentiation of normal ral osteoblasts. Each lane contains I ug of nuclear protein.
things C. S. and Â¿V.competition with I ug of HeLa nuclear extract. Lane 3. no competitor
(C); Lane S. OCT-l oligonucleotidc as specific competitor; Lane N, with Spl as nonspe
cific competitor oligonucleotide. The same probe and competitor DNA fragments were
used as described in Fig. 5A. B. regulation of AP-l binding activity during osteoblast
differentiation. Lane HELA. 4 ug of HeLa nuclear extract. PROL, 1.6. 3.1, 4.7, and 6.3
ug of proliferating ROB cells; DIFF.. I.I. 2.2. 3.3. and 4.4 ug of differentiated ROB
nuclear extracts. The probe spans an AP-l consensus sequence (see Fig. 5ÃŸ).
interaction changes during the up-regulation of OC expression when
ROS 17/2.8 cells cease to divide.
The down-regulation of TATA region complex A observed in ROS
17/2.8 cells at the cessation of proliferation (Fig. 6C) is similar to the
down-regulation of OCT-l (Fig. 5A) and HiNF-D (Fig. .14). When
ROS 17/2.8 cells reach confluency, these cells develop a partially
multilayered stratum of cells embedded in a dense collagen type I
extracellular matrix. However, in some experiments we have observed
that ROS I7/2.8 cells partially dissociate from the culture vessel
during the later stages (day 7 to day 10) of the culturing period (data
not shown). Nuclear protein preparations from these cultures did not
show a decreased abundance of the factor mediating TATA region
complex A, but no decrease was observed for OCT-l or HiNF-D
binding activity either. Although the reasons for cell dissociation
remain to be established, cell cultures subject to this phenomenon
displayed signs of continued cell division as visually evidenced by the
abundance of mitotic cells (data not shown). Presumably, cell prolif
eration in these cultures may reflect the colonization of areas on the
surface of the culture vessel that were rendered vacant due to cell
dissociation.
Selective Down-Regulation of Several H4 Gene Promoter Fac
tors during Normal Rat Osteoblast Development. It is of consid
erable interest to assess the extent to which the modification in tran
scription factor binding activities during ROS 17/2.8 cell growth
inhibition reflect events occurring during normal diploid osteoblast
differentiation. Similar to ROS I7/2.8 cells (4), normal diploid ROB
cells modify cell-stage-specific patterns of gene expression in part by
modulating gene transcription rates (13). We have previously shown
that transcriptional control of the histone H4 gene during osteoblast
differentiation is reflected by selective modifications in interactions of
/ra/i.v-activating factors with both proximal and distal d.t-acting ele
ments. For example, the interactions of HiNF-D with the proximal cell
cycle control domain H4 Site II and H4UA-1 with the distal stimu
latory domain H4 Site III are down-regulated upon cessation of his
tone gene transcription during the onset of differentiation in osteo
blasts (13, 33), as well as in other cell types (45). However, the
developmental regulation of several recently described H4 promoter
factors, including HiNF-M and HÃ•NF-P/H4TF-2 (17, 36). has not been
addressed.
To gain further insight into the regulation of both H4 gene tran
scription and the corresponding control of H4 promoter factors, it is
necessary to analyze H4 promoter DNA binding activities during both
the proliferative and differentiated stages of osteoblast phenotype
development using the same nuclear protein preparations. We per
formed gel mobility shift assays with promoter segments that span the
cell cycle control region of a prototypical H4 gene (Fig. 7). The data
show that nuclear factors HiNF-D (Fig. 1A) and HÃ•NF-P/H4TF-2
(Fig. IB) are detected only in proliferating ROB cells, whereas
HiNF-M (Fig. IB) is present in both rapidly dividing and differenti
ated osteoblasts. These results suggest that HiNF-D and HiNF-P/
H4TF-2. but not HiNF-M, are cell growth-controlled binding activi
ties and are selectively down-regulated in parallel at the onset of
differentiation. Most importantly, the regulation of these histone
DNA-binding activities is remarkably similar to that observed during
ROS I7/2.8 cell growth inhibition.
Constitutive Presence of Ubiquitous Transcriptional DNA-
binding Activities and Down-Regulation of OCT-l and AP-l dur
ing Cessation of Osteoblast Proliferation. To provide internal
standards for the presence and integrity of nuclear factors in our
protein preparations, we monitored the DNA-binding activities of
transcription factor families with broad promoter-binding specificity.
The nuclear abundance of promoter factors binding to Spl. ATF, and
CCAAT elements is similar in proliferating and differentiated ROB
cells (Fig. 8). The presence of these DNA-binding activities at both
developmental stages is consistent with their postulated roles in the
transcriptional activation of a plethora of genes (46). These results
establish that the changes in the nuclear abundance of histone pro
moter factors are selective and not due to quantitation errors or major
differences in the quality of our various nuclear protein preparations.
Our results also show (Fig. 9) that OCT-l and AP-l are present at
high levels in rapidly dividing ROB cells and are not present in
differentiated ROB cells. The down-regulation of OCT-1 and AP-1
during osteoblast differentiation corresponds with, respectively, the
cessation of cell cycle-dependent histone H2B gene transcription (59.
60) and the up-regulation of OC transcription (4) established in pre
vious studies. Comparison of results obtained with H4 gene promoter
factors HiNF-D and HÃŒNF-P/H4TF-2(Figs. 3 and 7), H2B gene pro
moter factor OCT-l. and AP-l binding activity (Figs. 5 and 9) sug
gests that these factors are regulated in concert and at least in part
subject to stringent growth regulation.
DISCUSSION
Osteosarcoma cells (ROS 17/2.8) (1, 2). unlike normal diploid
osteoblasts, do not form a mineralized extracellular matrix, the hall
mark of the mature osteoblast phenotype. Thus at least one key tran
sition point signaling the ultimate onset of osteoblast maturation is
clearly not operative. Moreover, expression of osteoblast-related
genes, which is functionally restricted to the postproliferative stages
of normal osteoblast development (3, 4), occurs at low levels in
proliferating ROS 17/2.8 cells. Hence, these cells display relaxation of
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gene-suppressive mechanisms that are operative on bone-related
genes during the proliferative period of normal diploid osteoblasts.
However, density-inhibited growth of ROS 17/2.8 cells results in the
shutdown of proliferation-specific genes and up-regulation of bone-
related genes from minimal levels by transcriptional mechanisms (4).
Here, we have studied this partial maintenance of the proliferation/
differentiation relationship in ROS 17/2.8 cells.
Our results show that shutdown of histone H4 and H2B gene
expression in confluent ROS 17/2.8 cells involves a corresponding
down-regulation of at least four key histone promoter factors. Two of
these, HiNF-D and HÃ•NF-P/H4TF-2, interact with a highly conserved
transcriptional element present in most histone H4 genes. This ele
ment (H4 Site II) mediates basal level and periodic, G,/S-phase-
specific modulations of transcription during the cell cycle (22). Sim
ilarly, OCT-I interacts with an analogous H2B promoter element (51,
54, 61 ). The fourth factor. H4UA-1, is involved in the enhancement of
histone gene transcription by a distal activating mechanism (33). The
correlation between the shutdown of histone gene expression in ROS
17/2.8 cells and specific modifications in a select subset of histone
promoter-binding activities interacting at both proximal and distal
domains supports our model for transcriptional regulation of individ
ual histone genes (14, 17). This model postulates contribution of
modularly organized promoter regulatory elements exhibiting selec
tive occupancy by a series of transcription factors in both a cell cycle-
and a cell growth-responsive manner. We have discussed previously
that at least three of these factors (HiNF-D, HiNF-M, and H4UA-1)
may represent heteromeric proteins and postulated that the regulated
activities of the putative components involve phosphorylation events
(17, 36). Thus, down-regulation of these factors may reflect the dis
sociation or inactivation of (possibly H4 gene-specific) transcription
factor complexes, rather than decreases in abundance of the indi-
vididual components. The current results are consistent with either
possibility.
With respect to specific mechanisms operative at the multipartite
cell cycle control element H4 Site II, we have studied the complete set
of H4 Site II binding activities within the same nuclear protein prep
arations as a function of the level of proliferative activity in both ROS
17/2.8 and normal diploid osteoblasts. Our results demonstrate that
apart from HiNF-D a second H4 Site II binding activity (i.e., HiNF-
P/H4TF-2) is proliferation dependent in both cell types. However,
unlike HiNF-D and HÃ•NF-P/H4TF-2, HiNF-M binding activity is not
coupled to cell proliferation. Thus, the H4 Site II transcriptional
element may integrate two types of intracellular gene-regulatory sig
nals: those monitoring cell cycle progression and those mediating
general transcriptional competency.
Coordinate cell cycle regulation of histone genes in normal diploid
osteoblasts involves collective modulation of protein/DNA interac
tions involving HiNF-D in histone H4, H3, and HI gene promoters
with respect to S phase (43. 62). However, these protein/DNA inter
actions are deregulated in concert and are constitutive during the ROS
17/2.8 cell cycle (43, 62). Hence, in addition to abrogated develop
mental regulation of critical transition points normally observed dur
ing osteoblast maturation, ROS 17/2.8 cells display relaxation of cell
cycle check points capable of modulating the level of HiNF-D binding
activity during the onset and following completion of S phase. Similar
deregulation of histone promoter factors occurs during the cell cycle
of HL60 promyelocytic leukemia cells, as well as other tumor-derived
and transformed cell types (43, 62). HL60 cells are capable of down-
regulating HiNF-D at the cessation of proliferation and onset of dif
ferentiation (45). Unlike HL60 cells, ROS 17/2.8 cells have lost the
competency to fully differentiate but are also capable of down-regu
lating the elevated, cell cycle-independent levels of HiNF-D binding
activity. These results suggest that regulation of HiNF-D is not only
coupled to cell cycle oscillatory mediators but also to regulatory
proteins capable of suppressing cell growth. Although we observed
dramatic changes in the expression of cell growth-related histone
genes and the cognate promoter binding activities during density
inhibition of ROS 17/2.8 cells, no major modifications in protein/
DNA interaction patterns were observed in the OC promoter at the
VDRE and OC box under the conditions examined here during the
up-regulation of OC expression from minimal basal levels. The con
stitutive binding activities interacting with these elements in the OC
promoter may maintain basal levels of OC transcription in both pro
liferating and confluent osteosarcoma cells. However, we observed a
novel nuclear factor interacting with a proximal promoter element of
the OC gene (nt -43 to -16) that contains a putative steroid receptor
recognition sequence overlapping with the TATA box consensus ele
ment. This factor is preferentially observed in proliferating ROS 17/
2.8 cells and is down-regulated when the OC gene is up-regulated.
Because this factor is most abundant when OC gene transcription is
minimal (4) and interacts in close proximity to the TATA element
specifying the initiation of mRNA synthesis, it is possible that this
novel protein may represent a member of the steroid hormone receptor
superfamily acting as a repressor of basal OC gene transcription.
The enhancement of the minimal level of OC expression during
ROS 17/2.8 proliferation arrest may also involve different mecha
nisms, i.e., posttranslational modifications of constitutive promoter
factors or modulation of factors interacting at regions outside those
examined. Also, up-regulation of OC expression from minimal basal
levels in ROS 17/2.8 cells is coupled with down-regulation of AP-1
activity. This event may relieve a component of transcriptional control
that suppresses the OC gene during active osteoblast proliferation (3,
5, 26). Regardless, the constitutive protein/DNA interactions occur
ring at the OC promoter, as well as the regulation of AP-1 activity,
provide a physiological context for the alterations in histone gene
protein/DNA interactions during ROS 17/2.8 density inhibition.
Direct comparison of results obtained during ROB development
and ROS 17/2.8 cell growth inhibition shows that the regulation of the
full complement of histone-specific and general promoter factors is
similar to that occurring during normal osteoblast differentiation. Be
cause ROS 17/2.8 cells do not differentiate into mature osteocytic
cells in a mineralized extracellular matrix, these events appear to be a
direct consequence of the cessation of proliferation rather than the
onset of differentiation. Thus, the partial maintenance of the
proliferation/differentiation relationship in ROS I7/2.8 cells, reflected
by the reciprocal regulation of the histone and OC genes, is directly
related to cell growth regulatory mechanisms that control the tran
scription of proliferation-specific histone genes by a selective decline
in the levels of the associated promoter DNA-binding activities. In
conclusion, the results presented in this study support a mechanistic
molecular model for the regulation of histone gene transcription (14)
in bone-derived cells. The observed differences in regulation of his
tone promoter binding activities during the cell cycle (43, 62) and
similarities in control at the cessation of proliferation in both normal
diploid and tumor-derived bone cells provide new avenues for further
studies on the molecular basis of neoplastic transformation in bone
tissue.
ACKNOWLEDGMENTS
We would like to thank Patricia Jamieson for editorial assistance; Christine
Dunshee for photography: as well as Donna Gonion. Jack Green. Maria Sattler,
and Rosa Mastrototaro for technical assistance. We also thank Arianne Hein
richs, Baruch Frenkel, Joseph Bidwell. Thomas Owen, and Vicky Shalhouh for
stimulating discussions.
2407
GENE REGULATION IN OSTEOSARCOMA CELLS
RKFKRENCES
1. Majeska. R. J.. Rodan. S. B., and Rodan, G. A. Parathyroid hormone-responsive
donai cell lines from ral osteosarcoma. Endocrinology, 107: 1494-1503, 1980.
2. Rodan. G. A., and Nodu. M. Gene expression in osteoblastic cells. Crii. Rev. Eukary-
otic Gene Exp.. // 85-98. 1991.
3. Stein. G. S.. Lian. J. B.. and Owen. T. A. Bone cell differentiation: a functionally
coupled relationship between expression of cell-growth and tissue-specific genes.
Curr. Opin. Cell Biol.. 2: 1018-1027, 1990.
4. Bortell. R.. Owen. T. A.. Shalhoub. V.. Heinrichs, A., Aronow, M. A., DeLuca, H.,
Stein. J. L.. Lian. J. B., and Stein. G. S. Constitutive transcription of the osteocalcin
gene in osteosarcoma cells is reflected by altered protein/DNA interactions at pro
moter regulatory elements. Proc. Nati. Acad. Sci. USA. 90: 2300-2304, 1993.
5. Lian. J. B.. Stein. G. S.. Bortell. R.. and Owen, T. A. Phenotype-suppression: a
postulated molecular mechanism for mediating the relationship of proliferation and
differentiation by Fos/Jun interactions at AP-1 sites in steroid responsive promoter
elements of tissue-specific genes. J. Cell. Biochem.. 45: 9-14, 1991.
6. Bhargava. U.. Bar-Lev. M., Bellows. C. G.. and Aubin, J. Ultrastructural analysis of
bone nodules formed in vilrti by isolated fetal rat calvarial cells. Bone, 9: 155-163.
1988.
7. Ecarot-Charrier. B.. Glorieux. F. H., van der Rest. M., and Pereira. G. Osteoblasts
isolated from mouse calvarÃ-ainitiate matrix mineralization in culture. J. Cell Biol..
96: 639-643. 1983.
8. Ecarot-Charrier, B.. Shepard, N., Chiarelle. G.. Grynpas, M., and Glorieux. F. H.
Mineralization in osteohlast cultures: a light and electron microscopic study. Bone. V:
147-154. 1988.
9. Bellows. C.G.. Aubin. J. E.. Heersche. H. N. M.. and Anlosz. M. E. Mineralized bone
nodules formed in vitro from enzymatically released rat calvarÃ-acell populations.
Calcif. Tissue Int., 38: 143-154. 1986.
10. Owen. T. A.. Aronow. M.. Shalhouh. V.. Barone, L. M., Wilming. L., Tassinari, M. S..
Kennedy. M. B.. Pockwinse. S.. Lian. J. B., and Stein, G. S. Progressive developmenl
of ihe rai osteoblasl phenotype in w'fro: reciprocal relationships in expression of genes
associated with osteoblast differentiation during formation of the bone extracellular
matrix. J. Cell. Physiol.. 143: 420-430. 1990.
11. Quarles. L. D.. Yohay. D. A.. Lever. L. W., CatÃ³n. R.. and Wensirup. R. J. Disiine!
proliferate and differentiated stages of murine MC3T3-EI cells in culture: an in
vilm model of osteoblasl development. J. Bone Miner. Res.. 7: 683-692, 1992.
12. Stein, G. S.. Lian. J. B., and Owen. T. A. Relationship of cell growth to the regulation
of tissue-specific gene expression during osteoblasl differentiation. FASEB J., 4:
3111-3123. 1990.
13. Owen. T. A.. Holthuis. J.. Markose. E.. van Wijnen. A. J., Wolfe, S. A., Grimes, S.,
Lian. J. B.. and Stein. G. S. Modifications of protein/DNA interactions in the proximal
promoter of a cell growth regulated hislone gene during onsel and progression of
osteoblasl differenliation. Proc. Nati. Acad. Sci. USA. 87: 5129-5133. 1990.
14. Slein, G. S.. Slein. J. L.. van Wijnen, A. J., and Lian, J. B. Regulation of histone gene
expression. Curr. Opin. Cell Biol., 4: 166-173. 1992.
15. Dallon. S.. and Wells. J. R. E. A gene-specific promoter elemenl is required for
oplimal expression of the hislone HI gene in S-phase. EMBO J.. 7: 49-56. 1988.
16. Gallinari. P., LaBella. F, and Heintz, N. Characterization and purification of H1TF-2.
a novel CCAAT-binding protein thai Â¡nleractswith a histone HI subtype-specific
consensus element. Mol. Cell. Biol., 9: 1566-1575. 1989.
17. van Wijnen. A. J.. van den Ent. F. M. I., Lian. J. B., Stein, J. L., and Slein G. S.
Overlapping and CpG methylalion senstiive prolein/DNA inleraclions at ihe hislone
H4 iranscriptional cell cycle domain: dislinctions between Iwo human H4 gene
promoters. Mol. Cell. Biol., 12: 3273-3287, 1992.
18. Wolfe, S. A., and Grimes. S. R. Prolein/DNA interactions within ihe ral H4i promoter.
J. Biol. Chem., 26(5. 6637-6643, 1991.
19. Choi. Y. C.. and Chae. C. B. DNA hypomethylalion and germ cell-specific expression
of testÃ¬s-specificH2B histone gene. J. Biol. Chem.. 266: 20504-20511. 1991.
20. Sharma. A., Bos, T. J., Pekkala-Flagan. A., Vogt. P. K.. and Lee. A. S. Interaclion of
cellular faclors related to the Jun oncoprotein with the promoler of a replicalion-
dependenl hamsier H3.2 gene. Proc. Nail. Acad. Sci. USA. 86: 491^495. 1989.
21. Wrighl. K. L. Functional and structural characterization of a human H4 histone gene
promoter. Doctoral thesis. University of Massachusetts Medical School. Worcester,
MA. 1990.
22. Ramsey-Ewing. A. Delineation of the human H4 cell cycle element in vivo and
examinalion of Â¡Isrole during cellular differentiation. Docloral ihesis, Universily of
Honda. Gainesville. FL. 1991.
23. Gerbaulet, S., van Wijnen. A. J., Aronin, N., Slein. J. L., Lian, J. B., and Slein, G. S.
Downregulalion of hislone H4 gene Iranscriplion during posl-nalal development in
transgenic mice and Iransgenically derived calvarial osleoblasi cultures. J. Cell. Bio
chem.. 87: 137-147, 1992.
24. van Wijnen, A. J., Choi. T.. Wright. K. L.. Jaenisch. R., Stein. J. L.. and Stein, G. S.
Involvement of the cell cycle regulaled nuclear factor HiNF-D in cell growlh control
of a human H4 histone gene during hepatic development in transgenic mice. Proc.
Nati. Acad. Sci. USA. 88: 2573-2577. 1991.
25. Markose. E. R.. Stein, J. L., Slein, G. S.. and Lian, J. B. Vilamin D-mediated
modifications in protcin/DNA interactions at Iwo promoter elements of the osleocal-
cin gene. Prix;. Nail. Acad. Sci. USA, 87: 1701-1705, 1990.
26. Owen. T. A.. Bonell. R.. Yocum. S. A.. Smock. S. L.. Zhang. M.. Abale. C.. Shalhoub.
V. Aronin. N.. Wright. K. L.. van Wijnen, A. J., Stein. J. L., Curran, T.. Lian, J. B..
and Stein. G. S. Coordinate occupancy of AP-1 sites in the vilamin D-responsive and
CCAAT-box elements by Fos-Jun in the osteocalcin gene: model for phenolype
suppression of Iranscriplion. Prix:. Nail. Acad. Sci. USA. 87: 9990-9994. 1990.
27. Bonell. R.. Owen. T. A., Bidwell, J. P.. Gavazzo. P.. Breen. E., van Wijnen. A. J..
DeLuca. H. F.. Slein. J. L.. Lian. J. B.. and Slein. G. S. Do multiple vitamin D receptor
binding elements synergistically contribule to Ihe level of osleocalcin gene promoler
2408
aclivily? Proc. Nail. Acad. Sci. USA. 89: 6119-6123. 1992.
28. Lian, J., Slewart, C.. Puchacz. E.. Mackowiak. S.. Shalhoub. V. Collari, D.. Zambelli.
G.. and Slein. G. Slructure of the ral osleocalcin gene and regulalion of vitamin
D-dependent expression. Proc. Nati. Acad. Sci. USA, 86: 1143-1147, 1989.
29. Demay. M. B., Gerardi, J. M.. DeLuca. H. F.. and Kronenberg. H. M. DNA sequences
in the rat osteocalcin gene that bind the 1.25-dihydroxyvitamin D, receptor, and
confer responsiveness lo 1,25-dihydroxyviiamin D.i. Proc. Nail. Acad. Sci. USA, 87:
369-373, 1990.
30. Ozono. K.. Liao. J., Kemer. S. A., Scon, R. A., and Pike, J. W. The vilamin D-re
sponsive elemenl in ihe human osteocalcin gene. J. Biol. Chem.. 265.- 21881-21888.
1990.
31. Terpening, C. M.. Haussler. C. A.. Jurutka, P. W., Galligan, M. A., Komm, B. S., and
Haussier, M. R. The vitamin D-responsive element in the rat bone-gla protein is an
imperfect direct repeat that cooperates wilh other n.v-elemenls in 1,25 dihydroxyvi-
tamin Di-mediated transcriptional activation. Mol. Endocrino!., 5: 373-385, 1991.
32. Owen. T. A.. Bortell. R., Shalhoub. V.. Heinrichs. A.. Stein. J. L.. Stein, G. S., and
Lian. J. B. Post-proliferalive transcription of the rat osleocalcin gene is reflecled by
vilamin D responsive developmenlal modifications in prolein/DNA interactions at
basal and enhancer promoter elements. Prix:. Nail. Acad. Sci. USA. 90: 1503-1507.
1993.
33. van der Houven van Oordl. C. W.. van Wijnen. A. J.. Carter. R.. Soprano. K., Lian.
J. B., Slein. G. S.. and Stein, J. L. Protein/DNA interactions at Ihe H4-Sile III
upstream transcriptional element of a cell cycle regulated histone H4 gene: differences
in normal veriÂ«.!tumor cells. J. Cell. Biochem.. 49: 93-110, 1992.
34. Dailey. L., Roberts. S. B.. and Heintz. N. Purification of the human histone H4
gene-specific transcription factors H4TF-I and H4TF-2. Genes Dev.. 2: 1700-1712.
1988.
35. van Wijnen. A. J.. Wright. K. L.. Lian. J. B.. Stein. J. L.. and Slein. G. S. Human H4
hislone gene Iranscriplion requires the proliferation-specific nuclear factor HiNF-D:
auxiliary roles for HiNF-C (Spl-like) and HiNF-A (high mobility group-like). J. Biol.
Chem.. 264: 15034-15042. 1989.
36. van Wijnen. A. J., Ramsey-Ewing, A.. Bortell, R.. Owen. T. A.. Lian. J. B.. Stein. J.
L.. and Stein. G. S. Transcriplional element H4-Site II of cell cycle regulated human
H4 gene transcription is a multi-panile prolein/DNA inleraclion sile for faclors
HiNF-D. HiNF-M and HiNF-P: involvement of phosphorylalion. J. Cell. Biochem..
46: 174-189. 1991.
37. Schepmoes. G., Breen. E.. Owen. T. A., Aronow. M. A.. Stein, G. S.. and Lian. J. B.
Influence of dexamethasone on the vitamin D mediated regulalion oi osleocalcin gene
expression. J. Cell. Biochem.. 47: 184-196. 1991.
38. Gundberg, C. M.. Hauschka, P. V., Lian, J. B.. and Gallop, P. M. Osteocalcin isolation,
characterization, and detection. Methods Enzymol., 107: 516-544. 1984.
39. Aronow. M. A.. Gerstenfeld. L. C.. Owen. T. A.. Tassinari, M. S., Slein, G. S., and
Lian, J. B. Faclors Â¡hatpromote progressive development of the osteoblast phenotype
in cultured fetal rat calvarial cells. J. Cell. Physiol., 14): 213-221. 1990.
40. Shalhoub. V. Jackson. M. E.. Lian, J. B., Stein. G. S.. and Marks. Jr.. S. C. Gene
expression during skelelal developmenl in ihree osteopetrolic ral mulalions: evidence
for osteohlasl abnormalilies. J. Biol. Chem.. 266: 9847-9856. 1991.
41. Ausubel, F. M., Brent. R.. Kingston. R. E.. Moore, D. D., Seidman. J. G., Smilh. J.
A., and Slruhl, K. (eds.). Current Protocols in Molecular Biology. New York: John
Wiley and Sons. Inc., 1987.
42. Dignam. J.. Lebovilz, R.. and Roeder, R. Accurate transcription initialion by RNA
polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids
Res., //.â€¢1475-1489, 1983.
43. van Wijnen. A. J.. Owen, T. A., Holthuis, J., Lian. J. B., Slein, J. L.. and Slein, G. S.
Coordinaron of prolein/DNA inleraclions in Ihe promolers of human H4. H.3 and HI
hislone genes during Ihe cell cycle, lumorigenesis and development. J. Cell. Physiol..
148: 174-189. 1991.
44. Stein, G. S.. Slein. J. L., and Marzluff. W. F. (eds.). Histone Genes. New York: John
Wiley and Sons, Inc., 1984.
45. Stein. G.. Lian, J., Stein. J.. Briggs, R., Shalhoub, V., Wright. K., Pauli, U., and van
Wijnen. A. J. Allered binding of human hislone gene Iranscriplion factors during the
shutdown of proliferation and onset of differentiation in HL-60 cells. Proc. Nati.
Acad. Sci. USA. 86: 1865-1869. 1989.
46. Mitchell. P. J., and Tjian, R. Transcriplional regulalion in mammalian cells by se
quence-specific DNA binding proteins. Science (Washington DC), 245: 371-378.
1989.
47. van Wijnen, A. J.. Wright, K. L., Massung, R. F.. Gerretsen, M.. Stein. J. L.. and Stein
G. S. Two targel siles for prolein binding in the promoter of a cell cycle regulaled
human HI hislone gene. Nucleic Acids Res., 16: 571-592, 1988.
48. van Wijnen. A. J.. Lian. J. B.. Slein. J. L., and Slein. G. S. Protein/DNA inleraclions
involving ATF/AP1-. CCAAT- and HiNF-D related faclors in Ihe human H3-ST5I9
hislone promoler: cross-competition with transcription regulatory sites in cell cycle
controlled H4 and HI histone genes. J. Cell. Biochem.. 47: 337-351. 1991.
49. Pauli. U.. Chrysogelos. S.. Stein. G.. Slein. J., and Nick. H. Prolein/DNA interaclions
in vivo upstream of a cell cycle regulated human H4 histone gene. Science (Wash
ington DC). 236: 1308-1311, 1987.
50. Pauli. U., Chrysogelos. S., Nick. H.. Stein. G.. and Stein. J. in v/vÂ»protein binding
siles and nuclease hypersensilivily in ihe promoter region of a cell cycle regulaled
human H3 hislone gene. Nucleic Acids Res.. 17: 2333-2350, 1989.
51. Flelcher, C.. Heintz, N.. and Roeder. R. Purification and characlerizalion of OTF-1.
a transcription factor regulaling cell cycle expression of a human histone H2b gene.
Cell, 51: 773-781. 1987.
52. Verrijzer. C. P., Kal, A., and van der Vliet. P. C. The ocl-l homeo domain conlacls
only pan of the octamer sequence and full oct-1 binding activity requires the POU-
specific domain. Genes Dev.. 4: 1964-1974. 1990.
GENE REGULATION IN OSTEOSARCOMA CELLS
53. Scholer. H. R. Octamania: thÃ©POU factors in murine development. Trends Genet.. 7:
323-328. 1990.
54. LaBella. F.. Gallinari, P.. McKinney. J., and Heintz, N. Histone HI subtype-specific
consensuselements mediate cell cycle regulated transcription in vitro. Genes Dev.. 3:
1982-1990, 1989.
55. Ito, M., Sharma, A.. Lee, A. S., and Maxson, R. Cell cycle regulation of H2h histone
octamer DNA binding activity in Chinesehamster lung fibroblasts. Mol. Cell. Biol.,
9: 869-873, 1989.
56. Curran. T.. and pranza. B. R. Fos and Jun: the AP-1 connection. Cell. 55: 395-397.
1988.
57. Karin. M. The AP-1 complex and its role in transcriptional control by protein kinase
C. In: P.Cohen and G. Foulkes (eds.). Molecular Aspects of Cellular Regulation. Vol.
6, pp. 143-161. Amsterdam: Elsevier/North Holland BiomÃ©dicalPress. 1990.
58. Heinrichs. A. A. J.. Banerjee. O. Bortell. R.. Owen. T. A.. Stein. J. L.. Stein. G. S..
and Lian. J. B. Evidence that protein-DNA interactions at a CCAAT element in the
rat osteocalcin gene promoter may modulate tissue-specific and developmenlally
regulated expression. American Society of Cell Biology Thirty-Second Annual
Meeting. Mol. Biol. Cell. J: 324a. 1992.
59. Collari. D.. Ramsey-Ewing. A.. Bortell. R.. Lian. J.. Croce. C.. Stein. J.. and Stein. G.
Isolation and characterization of a cDNA from a human histone H2B gene which is
reciprocally expressed in relation to replication-dependent H2B hisione genes during
HL60cell differentiation. Biochemistry, 30: 1610-1617, 1991.
60. Shalhoub. V., Gerslenfeld. L.. Collar!, D., Lian. J. B.. and Stein. G. S. Downregulation
of cell growth and cell cycle regulated genes during chick osteoblast differentiation
with the reciprocal expression of histone gene variants. Biochemistry. 2K: 5318-5322.
1989.
61. LaBella. F., Sive, H. L., Roeder, R. G.. and Heintz, N. Cell cycle regulation of a
human histone H2b gene is mediated by the H2h subtype-specific consensuselement.
Genes Dev.. 2: 32-39, 1988.
62. Holthuis, J., Owen, T. A., van Wijnen. A. J.. Wright. K. L.. Ramsey-Ewing. A..
Kennedy. M.. Carter. R.. Cosenza. S. C.. Soprano, K. J.. Lian. J. B.. Stein, J. L., and
Siein. G. S. Tumor cells exhibit deregulation of the cell cycle human histone gene
promoter factor HiNF-D. Science (Washington DC). 247: 1454-1457. 1990.
63. Heinrichs. A. A. J.. Bortell. R.. Stein. J. L.. Lilwack. G.. Stein. G. S.. and Lian. J. B.
Identification of multiple gluetÂ»corticoidreceptor binding sites within basal regulatory
elements of the rat osteocalcin promoter. American Society of Cell Biology Thirty-
Second Annual Meeting. Mol. Biol. Cell. J: I44a. 1992.
2409
